Softwr

Healthcare · head to head

Paige vs PioneerRx

Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite
PioneerRx logo

PioneerRx

Healthcare

Pharmacy management system built for independent community pharmacies

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.; PioneerRx pricing is not published, and total cost including hardware, interfaces and training is substantially above the monthly software figure
  • They diverge on capability: Paige covers Paige Prostate Detect, PioneerRx covers Prescription workflow.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Paige and PioneerRx actually diverge.

Attributes where Paige and PioneerRx differ
AttributePaigePioneerRx
PlatformsWeb, Cloud, On-premiseWindows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

Only in PioneerRx

  • Prescription workflow
  • Claims adjudication
  • Medication synchronisation
  • Clinical services
  • Inventory management
  • Patient communication

What people use each for

The jobs each tool is most often brought in to do.

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot PioneerRx
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot PioneerRx
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot PioneerRx
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot PioneerRx

PioneerRx

  • Independent community pharmacies competing with chains on servicenot Paige
  • Pharmacies building revenue from clinical services rather than dispensing margin alonenot Paige
  • Operations running medication synchronisation and adherence packagingnot Paige
  • Multi-location independents needing consistent workflow across storesnot Paige

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

PioneerRx

  • Pricing is not published, and total cost including hardware, interfaces and training is substantially above the monthly software figure
  • It is a Windows-centric system with a traditional interface, which shows against newer cloud entrants
  • More capability than a very low-volume pharmacy needs, and that capability has to be configured and learned
  • Switching pharmacy systems is disruptive because dispensing cannot pause, so migration planning matters more than in most software categories
  • US-only, with no relevance outside that regulatory and insurance environment

Pricing, plan by plan

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

PioneerRx

On request
  • PioneerRx$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Which should you pick?

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Choose PioneerRx if

  • You need prescription workflow.
  • You work on Windows, Web.
  • You also want claims adjudication.
PioneerRx review

Questions people ask

Is Paige or PioneerRx better?
Neither clearly leads. Paige starts at On request and PioneerRx at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Paige or PioneerRx?
Paige starts at On request and PioneerRx at On request.
Does Paige or PioneerRx run on more platforms?
Paige runs on Web, Cloud, On-premise. PioneerRx runs on Windows, Web.
What is Paige best used for?
Paige is most often used for a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable, a pathology department already digitised that wants a documented safety net against missed small foci of cancer, a hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reporting, a pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variability. Of those, a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable and a pathology department already digitised that wants a documented safety net against missed small foci of cancer are not what PioneerRx is typically brought in for.
What can Paige do that PioneerRx cannot?
Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications. PioneerRx covers Prescription workflow, Claims adjudication, Medication synchronisation, Clinical services.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

PioneerRx: Who is PioneerRx for?

Independent community pharmacies in the United States, explicitly. Its development priorities target the things that help an independent compete with a chain.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

PioneerRx: What does it cost?

Not published. Expect a monthly software fee plus hardware, interface and training costs, and ask for the total rather than the headline.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

PioneerRx: Why do clinical services matter so much?

Dispensing margin has been compressed for years. Immunisations, medication therapy management and point-of-care testing are where independents now make money, so the software support for documenting and billing them is a commercial question rather than a feature preference.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

PioneerRx: How disruptive is switching?

Meaningfully. A pharmacy cannot stop dispensing during a migration, so data conversion, staff training and a cutover plan need real preparation.

PioneerRx: Does it work outside the US?

No. It is built around US insurance adjudication and regulatory requirements.

Share

Related pages

More on Paige

More on PioneerRx

Keep looking

Other head to heads